Mie multicenter registry of hemodialysis patients undergoing PCI with drug-eluting stent

Trial Profile

Mie multicenter registry of hemodialysis patients undergoing PCI with drug-eluting stent

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 28 Dec 2015

At a glance

  • Drugs Everolimus (Primary) ; Paclitaxel (Primary)
  • Indications Coronary artery disease; Coronary artery restenosis
  • Focus Therapeutic Use
  • Acronyms MY HOPE
  • Most Recent Events

    • 11 Dec 2015 Status changed from active, no longer recruiting to discontinued, as per University Hospital Medical Information Network - Japan record.
    • 27 Jun 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top